| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |